AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsitePF-543 Citrate is a novel cell-permeant inhibitor of SphK1 with a K(i) of 3.6 nM, PF-543 is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.
More Information Supplier PagePF-543 Citrate is a novel cell-permeant inhibitor of SphK1 with a K(i) of 3.6 nM, PF-543 is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.
More Information Supplier PagePF-543 Citrate is a novel cell-permeant inhibitor of SphK1 with a K(i) of 3.6 nM, PF-543 is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.
More Information Supplier PagePF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
More Information Supplier PagePF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.
More Information Supplier PagePF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.
More Information Supplier PagePF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.
More Information Supplier PagePF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4.
More Information Supplier PagePF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4.
More Information Supplier PagePF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4.
More Information Supplier PagePF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4.
More Information Supplier PagePF299804 is a potent, orally available, irreversible inhibitor of tyrosine kinase human epidermal growth factor receptors (HER) 1 (EGFR), HER2, and HER4.
More Information Supplier PagePF6-AM is a new selective fluorescent indicator for hydrogen peroxide (H(2)O(2)), a tool to help discover new redox chemistry in biological systems.
More Information Supplier PagePF6-AM is a new selective fluorescent indicator for hydrogen peroxide (H(2)O(2)), a tool to help discover new redox chemistry in biological systems.
More Information Supplier PagePF6-AM is a new selective fluorescent indicator for hydrogen peroxide (H(2)O(2)), a tool to help discover new redox chemistry in biological systems.
More Information Supplier PagePFI-1 is a BET bromodomain inhibitor that exhibits inhibitory activity at BRD2 and BRD4.
More Information Supplier PagePFI-1 is a BET bromodomain inhibitor that exhibits inhibitory activity at BRD2 and BRD4.
More Information Supplier PagePFI-1 is a BET bromodomain inhibitor that exhibits inhibitory activity at BRD2 and BRD4.
More Information Supplier PagePFI-1 is a BET bromodomain inhibitor that exhibits inhibitory activity at BRD2 and BRD4.
More Information Supplier PagePFI-1 is a BET bromodomain inhibitor that exhibits inhibitory activity at BRD2 and BRD4.
More Information Supplier PagePFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM, 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.
More Information Supplier PagePFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM, 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.
More Information Supplier PagePFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM, 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.
More Information Supplier PagePFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM, 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.
More Information Supplier PagePFK-158 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFK-2/FBPase) isoform 3 (PFKFB3) and derivative of 3-(3-pyridinyl)-1-[4-pyridinyl]-2-propen-1-one (3PO), with potential antineoplastic activity.
More Information Supplier PagePFK-158 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFK-2/FBPase) isoform 3 (PFKFB3) and derivative of 3-(3-pyridinyl)-1-[4-pyridinyl]-2-propen-1-one (3PO), with potential antineoplastic activity.
More Information Supplier PagePFK-158 is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFK-2/FBPase) isoform 3 (PFKFB3) and derivative of 3-(3-pyridinyl)-1-[4-pyridinyl]-2-propen-1-one (3PO), with potential antineoplastic activity.
More Information Supplier PagePFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.
More Information Supplier PagePFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.
More Information Supplier PagePFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.
More Information Supplier PagePFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PagePHA 408 is a potent, highly selective and ATP-competitive IKB kinase-2 (IKK-2) inhibitor (IC50: 40 nM), which binds IKK-2 tightly with a relatively slow off rate; highly recommended tool to investigate the mechanisms by which IKK-2 regulates NF-KB signaling.
More Information Supplier PagePHA 408 is a potent, highly selective and ATP-competitive IKB kinase-2 (IKK-2) inhibitor (IC50: 40 nM), which binds IKK-2 tightly with a relatively slow off rate; highly recommended tool to investigate the mechanisms by which IKK-2 regulates NF-KB signaling.
More Information Supplier PagePHA 408 is a potent, highly selective and ATP-competitive IKB kinase-2 (IKK-2) inhibitor (IC50: 40 nM), which binds IKK-2 tightly with a relatively slow off rate; highly recommended tool to investigate the mechanisms by which IKK-2 regulates NF-KB signaling.
More Information Supplier PagePHA 408 is a potent, highly selective and ATP-competitive IKB kinase-2 (IKK-2) inhibitor (IC50: 40 nM), which binds IKK-2 tightly with a relatively slow off rate; highly recommended tool to investigate the mechanisms by which IKK-2 regulates NF-KB signaling.
More Information Supplier Page
